New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
06:22 EDTHZNP, CVS, ESRXHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Horizon Pharma (HZNP) said it has been verbally notified that in August, two pharmacy benefit managers, CVS Caremark (CVS) and Express Scripts (ESRX), expect to announce DUEXIS and VIMOVO will no longer be on their formularies and will be placed on their exclusion lists effective January 1, 2015. As a change in Caremark and ESI formulary status would not take effect until 2015, Horizon Pharma does not expect this potential action to impact the financial guidance of $270M-280M for net revenues and $80M-90M for adjusted EBITDA for fiscal 2014 as provided in first quarter earnings press release dated May 9. In response to potentially being placed on Caremarkís and ESIís exclusion lists, the company said it will immediately accelerate patient and physician focused commercial model to focus prescriptions through other channels such as our Prescriptions Made Easy program, continue working with many of the other PBMs and evaluate price increases. We estimate approximately 20%-30% of DUEXIS and VIMOVO prescriptions could be impacted by the potential actions by Caremark and ESI. In the future, if additional healthcare plans adopt the Caremark or ESI exclusion lists or otherwise exclude DUEXIS or VIMOVO from the formularies they use, which they are not required to do, there could possibly be additional DUEXIS and VIMOVO prescriptions affected.
News For HZNP;CVS;ESRX From The Last 14 Days
Check below for free stories on HZNP;CVS;ESRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
09:19 EDTHZNPHorizon Pharma announces holder approval of Vidara acquisition
Subscribe for More Information
September 16, 2014
06:21 EDTHZNPHorizon Pharma to host special shareholder meeting
Special shareholder meeting to consider and seek shareholder approval of the acquisition of Vidara Therapeutics, will be held in Deerfield, IL on September 18 at 9 am.
September 15, 2014
09:59 EDTCVSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:12 EDTHZNPHorizon Pharma valuation at attractive entry point, says Cowen
Subscribe for More Information
07:24 EDTCVSCVS Health upgraded at Cowen
Subscribe for More Information
06:07 EDTCVSCVS Health upgraded to Outperform from Market Perform at Cowen
September 11, 2014
10:00 EDTESRXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:30 EDTESRXExpress Scripts downgraded to Neutral from Buy at Goldman
Subscribe for More Information
September 9, 2014
10:09 EDTHZNPHorizon Pharma initiated with an Outperform at Avondale (pre-open)
Subscribe for More Information
September 8, 2014
08:01 EDTCVSCVS Health completes purchase of Navarro Discount Pharmacy
Subscribe for More Information
07:26 EDTCVSMorgan Stanley to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use